UNDERWRITING AGREEMENTUnderwriting Agreement • June 14th, 2018 • British Columbia
Contract Type FiledJune 14th, 2018 JurisdictionEight Capital (the “Underwriter”) understands that InMed Pharmaceuticals Inc. (the “Company”) proposes to issue and sell 14,444,560 units of the Company (the “Firm Units”), consisting of one common share of the Company (a “Unit Share”), and one common share purchase warrant (a “Warrant”) at a price of $0.90 per Firm Unit (the “Offering Price”), for gross proceeds to the Company of $13,000,104 (the “Offering”). Each Warrant will entitle the holder thereof to purchase one common share of the Company (a “Warrant Share”) for a period of 24 months after the Closing Date (as defined herein) at an exercise price of $1.25 per Warrant Share.